cardiovascular comorbidity – Page 5 – Communicable Diseases Research

SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease

Cardiology

Published on 2020-06-112022-10-31
Journal: Cureus
[Category] COVID-19,

[키워드] ACE acute respiratory distress syndrome association blockers cardiac cardiac function cardiovascular comorbidity caused Comorbidities contracting the virus Coronary artery disease coronary disease coronavirus country COVID 19 described effort enzyme II expression global pandemic greater heart failure hypertension idiopathic hypertension increased risk ischemic heart disease less management mechanism medical condition morbidity and mortality Novel coronavirus Patient patients prescribed medications reported risk SARS-CoV-2 sars-cov-2 (severe acute respiratory syndrome coronavirus -2) Scientific community serious infection Society Spread the disease the SARS-CoV-2 virus Western world Wuhan, China
[DOI] 10.7759/cureus.8557 PMC 바로가기 [Article Type] Cardiology

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies

IM-Point of view

Published on 2020-05-192022-10-30
Journal: Internal and Emergency Medicine
[Category] COVID-19, MERS, SARS,

[키워드] “cytokine storm” ACE-2 ACE-inhibitors angiotensin II receptor blockers Angiotensin-converting enzyme angiotensin-converting enzyme inhibitor ARB ARBs benefit binding blocker cardiovascular comorbidity cardiovascular disease cardiovascular diseases Cell cell types characterized China chromosome claimed Clinical course Clinical practice coding COVID-19 Deceased diabete disease Disseminated intravascular coagulation downregulation drugs Effect Effects Endothelial cell endothelial cells Endothelium enzyme epidemiological situation Evidence experimental model expressed expression female patient hazard host’s cell humans hypertension implication in vivo Infection intestinal involved Italian kidney molecular Mortality most prevalent comorbidity mRNA Neutral Occurrence Older Patient patients treated patients with COVID-19 Prospective Study protein level question Randomized receptor renal reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor SARS-CoV-2-infected patients smoking Spike protein subsequent targets therapy Thromboembolism thrombosis tissues TMPRSS2 protease treated Treatment Vasculitis worse prognosis
[DOI] 10.1007/s11739-020-02364-6 PMC 바로가기 [Article Type] IM-Point of view

Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review

Review

Published on 2020-05-112022-10-28
Journal: Viruses
[Category] COVID-19, MERS, SARS,

[키워드] Acute cardiac injury acute respiratory syndrome adverse outcome association Biomarker cardiovascular cardiovascular comorbidity cardiovascular complications cardiovascular disease cardiovascular risk factor caused Coagulation coronavirus coronavirus disease COVID-19 COVID-19 case COVID-19 outbreak CVD death Evidence exacerbate highlight hospitalised COVID-19 patients identify imperative increased risk intensive care unit Laboratory testing morbidity and mortality mortality rate myocardial injury outcomes Patient Prevalence Prognosis Prognostic factor raised reported review risk factor SARS-CoV-2 severity shown value virus while worse prognosis Wuhan, China
[DOI] 10.3390/v12050527 PMC 바로가기 [Article Type] Review

Impact of COVID-19 on the Cardiovascular System: A Review

Review

Published on 2020-05-092022-10-30
Journal: Journal of Clinical Medicine
[Category] COVID-19,